GI/endoscopy company stock report – March 27, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for March 23 to March 27.

Advertisement

•    AbbVie: $57.61 per share (up 0.63 percent)
•    Boston Scientific: $17.73 per share (up 1.66 percent)
•    FUJIFILM Holdings: 4,213.50 per share (JPY) (down 0.85 percent)
•    Olympus: 4,450 per share (JPY) (down 0.22 percent)
•    Salix Pharmaceuticals: $172.74 per share (up 0.06 percent)

More articles on gastroenterology:
Dr. Atif Iqbal: Using the LINX device for GERD treatment
6 reasons patients avoid undergoing screening colonoscopy
GI physician leader to know: Dr. Gary Gitnick of University of California, Los Angeles

Advertisement

Next Up in GI & Endoscopy

  • Discontinuing GLP-1 treatment does not always cause significant weight gain, as many patients transition to other obesity or diabetes treatments,…

  • Health systems across the U.S. are continuing to expand outpatient digestive health services, with five new gastroenterology and endoscopy centers…

Advertisement

Comments are closed.